Safety and Efficacy of Firmagon® (Degarelix) for Injection

Clinical trial NCT02886598 · COMPLETED

Trial details

NCT number: NCT02886598
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2016-09-01
Primary completion: 2019-03-26
Enrollment: 368

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.